close

Fundraisings and IPOs

1 63 64 65 66 67 74
Number of results: 1471
Date Company Amount Funding type Investors Therapeutic area Type of Information
2012-02-07 Pieris (Germany) € 1 million grant Federal Ministry of Education and Research (BMBF) (Germany) Cancer - Oncology Grant
2012-02-01 Wilex (Germany) € 9.93 million private placement Cancer - Oncology - Inflammatory diseases Private placement
2012-01-30 Algenics (France) undisclosed - This grant is part of a €700 000 phase 1 project. grant OSEO (France) Technology - Services Grant
2012-01-25 Targovax (Norway) 18.5 million NOK (€2.41 million) financing round Radium Hospital Research Foundation (Norway) - Birk Venture (Norway) - RO Invest (Norway) - existing owners Cancer - Oncology Fundraising
2012-01-23 Prosensa (The Netherlands) €23 Million equity financing New Enterprise Associates (USA)
Abingworth (UK)
Life Sciences Partners (The Netherlands)
Gimv (Belgium)
Idinvest Partners (France)
MedSciences Capital (The Netherlands)
Rare diseases - Genetic diseases Fundraising
2012-01-23 Eyevensys (France) €1.6 million capital increase InnoBio (France) - nserm Transfert Initiative (France) Ophtalmological diseases Fundraising
2012-01-20 Pronota (Belgium) € 3.7 mil­lion series C financing round LSP (The Netherlands) - Gimv (Belgium) - Biotech Fund Flanders (Belgium) - KBC Private Equity  (Belgium) - Johnson & Johnson Development Corporation (USA) - VIB (Belgium) - MP Healthcare (USA) - MedSciences Capital (The Netherlands)
a com­pany founder
Cancer - Oncology - Infectious diseases Fundraising
2012-01-18 Pluristem Therapeutics (Israel) NIS 9 million (approximately $2.4 million - €1.8 million) grant Office of the Chief Scientist (OCS -Israel) Cardiovascular diseases - Regenerative medicine Grant
2012-01-18 Pherecydes Pharma (France) €900 000 grant DGA - Infectious diseases Grant
2012-01-18 Oxford Cancer Biomarkers (UK) undisclosed private investment

Quintiles (USA)

2012-01-12 ProteoMediX (Switzerland) CHF 2.6 million (€2.1 million) Series A equity financing round Altos Venture (Switzerland) - BioValley Business Angels Club BioBAC (Switzerland) - Zürcher Kantonalbank (Switzerland) Cancer - Oncology Fundraising
2012-01-12 Cell Medica (UK) grant Technology Strategy Board (UK) Cancer - Oncology - Infectious diseases Grant
2012-01-10 Telormedix (Switzerland) CHF 7.5 Million (€6.1million) Aravis Venture ( Switzerland) - Proquest Investments (USA) Cancer - Oncology - Inflammatory diseases Establishment of a new subsidiary in the EU
2012-01-05 AMP Therapeutics (Germany) undisclosed series A financing round Boehringer Ingelheim Venture Fund (Germany) - Novartis Venture Fund (Switzerland) Infectious diseases Fundraising
2012-01-05 Midatech (UK) £6.3 Million (€7.6 million) private investment Cancer - Oncology Private placement
2012-01-04 Probiodrug (Germany) €15 Million fundraising Inflammatory diseases - Neurodegenerative diseases Fundraising
2012-01-04 BerGenBio (Norway) $8.8 million (€6.8 million) Series A financing round Sarsia Seed AS (Norway) - Investinor AS (Norway) Cancer - Oncology Fundraising
2012-01-04 Pharmalink (Sweden) SEK 35 million (€4million) existing shareholders Renal diseases Fundraising
2012-01-02 Galecto Biotech (Sweden) seed financing Merck Serono Ventures (Switzerland) - Novo A/S (Denmark) - Forskarpatent (Sweden) Inflammatory diseases Fundraising
2011-12-30 Amsterdam Molecular Therapeutics (the Netherlands) €2.5 million private placement Forbion Capital Partners (The Netherlands) - Gilde Healthcare Partners (The Netherlands) - Advent Venture Partners (UK) Rare diseases - Genetic diseases Private placement